2.3. Expression of Full-Length Dysferlin or Its C or N-Terminal Regions Restores G-Actin Incorporation in Dysferlinopathy Myoblasts. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.